{
  "id": "54ede34694afd61504000004",
  "type": "summary",
  "question": "Which is the genetic cause for the development of Fanconi anemia complementation group D1?",
  "ideal_answer": "Fanconi anemia complementation group D1 (FANCD1) was shown to be induced by biallelic mutations in the BRCA2 breast-cancer-susceptibility gene.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/15695377",
    "http://www.ncbi.nlm.nih.gov/pubmed/15645491",
    "http://www.ncbi.nlm.nih.gov/pubmed/18212739",
    "http://www.ncbi.nlm.nih.gov/pubmed/14559878",
    "http://www.ncbi.nlm.nih.gov/pubmed/14695169",
    "http://www.ncbi.nlm.nih.gov/pubmed/12383764",
    "http://www.ncbi.nlm.nih.gov/pubmed/16920162"
  ],
  "snippets": [
    {
      "text": "The discovery of biallelic BRCA2 mutations in the FA-D1 complementation group allows for the first time to study the characteristics of primary BRCA2-deficient human cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16920162",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Although he lacked a strong family history of cancer, he was subsequently shown to carry biallelic mutations in the FANCD1/BRCA2 gene. These included an IVS7 splice-site mutation, which is strongly associated with early AML in homozygous or compound heterozygous carrier status in FA-D1 patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15645491",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Biallelic BRCA2 mutations were shown recently to cause FA-D1. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14695169",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "One kindred, of Ashkenazi Jewish ancestry, had five members who were diagnosed with breast cancer and two cousins who were BRCA2*6174delT/C3069X compound heterozygotes and had Fanconi anemia and brain tumors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In another kindred of Ashkenazi Jewish and Lithuanian Catholic ancestry, a child with Fanconi anemia and a medulloblastoma was a BRCA2*6174delT/886delGT compound heterozygote",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; one child was of Latin American ancestry and a compound heterozygote for BRCA2*I2490T/ 5301insA and the other was African American and a compound heterozygote for BRCA2*Q3066X/E1308X",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Surprisingly, biallelic mutations in the BRCA2 breast-cancer-susceptibility gene were found in Fanconi anemia (FA), a rare hereditary disorder characterized by chromosomal instability, hypersensitivity to DNA cross-linking agents, and cancer susceptibility",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12383764",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Biallelic mutations in Fanconi anemia complementation group genes disrupt DNA repair and result in the complex Fanconi anemia phenotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15695377",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thirteen complementation groups and genes are identified, including BRCA2, which is defective in the FA-D1 group.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18212739",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Biallelic BRCA2 mutations were shown recently to cause FA-D1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14695169",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Biallelic BRCA2 mutations were shown recently to cause FA-D1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14695169",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thirteen complementation groups and genes are identified, including BRCA2, which is defective in the FA-D1 group",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18212739",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D024682",
    "http://www.uniprot.org/uniprot/BRCA2_MOUSE"
  ]
}